下调和上调
胶质瘤
生物
蛋白激酶B
细胞生长
小RNA
癌症研究
小发夹RNA
受体酪氨酸激酶
细胞生物学
基因敲除
PI3K/AKT/mTOR通路
信号转导
细胞培养
基因沉默
生物化学
遗传学
基因
作者
Yuan-Yuan Liu,Min‐Bin Chen,Long Cheng,Zhi-qing Zhang,Zhengquan Yu,Qin Jiang,Gang Chen,Cong Cao
出处
期刊:Oncogene
[Springer Nature]
日期:2018-03-07
卷期号:37 (21): 2890-2902
被引量:94
标识
DOI:10.1038/s41388-018-0184-5
摘要
We previously identified a pivotal role for G protein α inhibitory subunit 1 (Gαi1) in mediating PI3K-Akt signaling by receptor tyrosine kinases (RTKs). Here, we examined the expression and biological function of Gαi1 in human glioma. Gαi1 mRNA and protein expression were significantly upregulated in human glioma tissues, which correlated with downregulation of an anti-Gαi1 miRNA: microRNA-200a (miR-200a). Forced-expression of miR-200a in established (A172/U251MG lines) and primary (patient-derived) human glioma cells resulted in Gαi1 downregulation, Akt inactivation and proliferation inhibition. Reduction of Gαi1 expression by shRNA, dominant negative mutant interference, or complete Gαi1 depletion inhibited Akt activation and cell proliferation. Notably, miR-200a was unable to inhibit glioma cell proliferation when Gαi1 was silenced or mutated. Co-immunoprecipitation studies, in human glioma cells and tissues, show that Gαi1 forms a complex with multiple RTKs (EGFR, PDGFRα, and FGFR) and the adapter protein Gab1. In vivo, the growth of subcutaneous and orthotopic glioma xenografts in nude mice was largely inhibited by expression of Gαi1 shRNA or miRNA-200a. Collectively, miR-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation and glioma cell proliferation.
科研通智能强力驱动
Strongly Powered by AbleSci AI